IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 13248 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


A case of capecitabine-induced dermatomyositis

Saraswat Neerja, Verma Rajesh, Neema Shekha, Kumar Sushil

Year : 2018| Volume: 50| Issue : 6 | Page no: 350-353

   This article has been cited by
1 Antitranscriptional intermediary family-1? antibody-positive dermatomyositis in a patient with triple-negative breast cancer treated with adjuvant capecitabine
Alaina J. Kessler, Andrew Para, George W. Niedt, Paula Klein
JAAD Case Reports. 2023;
[Pubmed]  [Google Scholar] [DOI]
2 Management of Cancer-Associated Myositis
Albert Selva-O’Callaghan, Ernesto Trallero-Araguás, Javier Ros, Albert Gil-Vila, Julia Lostes, Antonia Agustí, Judit Riera-Arnau, Marcelo Alvarado-Cárdenas, Iago Pinal-Fernandez
Current Treatment Options in Rheumatology. 2022;
[Pubmed]  [Google Scholar] [DOI]
3 Capecitabine-induced activation of actinic keratosis: A common but underrecognized adverse event
Samantha Marley, Shelly Stepenaskie, Naiara S. Barbosa
Current Problems in Cancer: Case Reports. 2021; 3: 100050
[Pubmed]  [Google Scholar] [DOI]
4 Dermatomyositis induced by the secretion of Phyllomedusa bicolor or Kambô frog - A case report
Mariana de la Vega, Gilberto Maldonado, Arnoldo Kraus
Toxicon. 2020; 184: 57
[Pubmed]  [Google Scholar] [DOI]
5 Antibody–drug conjugates, cancer immunotherapy, and metronomic chemotherapy as novel approaches in cancer management
SudhirChandra Sarangi, Pranav Sopory, SoumyaSucharita Pattnaik, KH Reeta
Indian Journal of Pharmacology. 2020; 52(5): 402
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow